200,000+ products from a single source!
sales@angenechem.com
188627-80-7 | L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide
CAS No: 188627-80-7 Catalog No: AG001FDT MDL No:MFCD05662245
Product Description
Catalog Number:
AG001FDT
Chemical Name:
L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide
CAS Number:
188627-80-7
Molecular Formula:
C35H49N11O9S2
Molecular Weight:
831.9619
MDL Number:
MFCD05662245
SMILES:
OC(=O)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)Cc1c[nH]c3c1cccc3)CCC2)C(=O)N
Literature
| Title | Journal |
|---|---|
| Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin. | Platelets 20130101 |
| Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates. | Clinical and experimental medicine 20121201 |
| The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day. | Drugs 20121112 |
| Efficiency of enrollment in a successful phase II acute stroke clinical trial. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20121101 |
| Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). | The American journal of cardiology 20121001 |
| Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. | Anesthesia and analgesia 20120901 |
| Perioperative management of a neurosurgical patient requiring antiplatelet therapy. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20120901 |
| Safety of 'bridging' with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. | The American journal of cardiology 20120815 |
| Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany. | The European journal of health economics : HEPAC : health economics in prevention and care 20120801 |
| Perioperative management of a patient with recently placed drug-eluting stents requiring urgent spinal surgery. | Journal of general internal medicine 20120801 |
| GP IIb/IIIa inhibitors for STEMI: still the gold standard or an old survivor? | Current vascular pharmacology 20120701 |
| Intracoronary use of GP IIb/IIIa inhibitors in percutaneous coronary interventions. | Current vascular pharmacology 20120701 |
| Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. | Circulation. Heart failure 20120701 |
| Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. | Blood 20120628 |
| Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction. | Molecular therapy : the journal of the American Society of Gene Therapy 20120501 |
| Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. | American heart journal 20120501 |
| Integrin α PAT-2/CDC-42 signaling is required for muscle-mediated clearance of apoptotic cells in Caenorhabditis elegans. | PLoS genetics 20120501 |
| Mechanisms of Platelet Activation and Integrin αIIβ3. | Korean circulation journal 20120501 |
| Adjusting eptifibatide doses for renal impairment: a model of dosing agreement among various methods of estimating creatinine clearance. | The Annals of pharmacotherapy 20120401 |
| From snake venom toxins to therapeutics--cardiovascular examples. | Toxicon : official journal of the International Society on Toxinology 20120315 |
| Routine upstream versus selective downstream administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-elevation acute coronary syndromes: a meta-analysis of randomized trials. | International journal of cardiology 20120308 |
| A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim. | Heart, lung & circulation 20120301 |
| Bleeding risk and safety profile related to the use of eptifibatide: a current review. | Expert opinion on drug safety 20120301 |
| Clinical outcomes of intracoronary eptifibatide bolus only versus intracoronary bolus and intravenous infusion of eptifibatide in primary percutaneous coronary intervention. | Acute cardiac care 20120301 |
| Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis. | Current medical research and opinion 20120301 |
| Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20120301 |
| Antiplatelet and anticoagulant drugs in interventional radiology. | Cardiovascular and interventional radiology 20120201 |
| Contemporary use of glycoprotein IIb/IIIa inhibitors. | Thrombosis and haemostasis 20120201 |
| Acute stent thrombosis: technical complication or inadequate antithrombotic therapy? An optical coherence tomography study. | JACC. Cardiovascular interventions 20120201 |
| In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. | The Journal of clinical investigation 20120103 |
| Bridging therapy after recent stent implantation: case report and review of data. | Cardiovascular revascularization medicine : including molecular interventions 20120101 |
| Mapuche herbal medicine inhibits blood platelet aggregation. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| Incidence of bleeding in renally impaired patients receiving incorrectly dosed eptifibatide or bivalirudin while undergoing percutaneous coronary intervention. | The Annals of pharmacotherapy 20120101 |
| Recent advances in epidural analgesia. | Anesthesiology research and practice 20120101 |
| Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. | BMJ (Clinical research ed.) 20120101 |
| Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy. | Cardiology research and practice 20120101 |
| Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty. | Vascular health and risk management 20120101 |
| Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. | Texas Heart Institute journal 20120101 |
| All-trans-retinoic acid ameliorated high fat diet-induced atherosclerosis in rabbits by inhibiting platelet activation and inflammation. | Journal of biomedicine & biotechnology 20120101 |
| Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis. | International journal of cell biology 20120101 |
| Summary of product characteristics (SmPC)--study on utilization of information presented in SmPC by different groups of physicians. | Acta poloniae pharmaceutica 20120101 |
| Surface modification of biomaterials: a quest for blood compatibility. | International journal of biomaterials 20120101 |
| [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation]. | Giornale italiano di cardiologia (2006) 20120101 |
| Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade. | PloS one 20120101 |
| Microvascular effect of intracoronary eptifibatide in acute myocardial infarction. | Cardiology 20120101 |
| Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells. | PloS one 20120101 |
| Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. | The Annals of thoracic surgery 20111201 |
| The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial. | American heart journal 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Mitral stenosis as a risk factor for embolic myocardial infarction--anticoagulation for some patients, individual treatment for all. | Heart, lung & circulation 20111101 |
| Current issues with glycoprotein IIb-IIIa antagonists. | Current drug targets 20111101 |
| Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention. | Annals of medicine 20111101 |
| Anticoagulant, anti-aggregation and antithrombotic effects of a novel hexapeptide. | The Journal of pharmacy and pharmacology 20111101 |
| Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome. | The American journal of cardiology 20111101 |
| Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function. | American heart journal 20111101 |
| Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions. | Drugs 20111022 |
| Lytic resistance of fibrin containing red blood cells. | Arteriosclerosis, thrombosis, and vascular biology 20111001 |
| The original sin committed in years two thousand. | Journal of interventional cardiology 20111001 |
| Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes. | International journal of cardiology 20110915 |
| [Diagnostic laparoscopy under dual antiplatelet therapy with clopidogrel and aspirin]. | Medizinische Klinik, Intensivmedizin und Notfallmedizin 20110901 |
| Advanced assessment of platelet function during adult donor care. | Progress in transplantation (Aliso Viejo, Calif.) 20110901 |
| Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. | Journal of interventional cardiology 20110801 |
| Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke. | Stroke 20110801 |
| Poly-N-acetyl glucosamine fibers accelerate hemostasis in patients treated with antiplatelet drugs. | The Journal of trauma 20110801 |
| Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. | Circulation. Cardiovascular quality and outcomes 20110701 |
| Safety and efficacy of tirofiban as adjunctive therapy for patients with ST-elevation myocardial infarction: a comparison versus placebo and abciximab. | Cardiovascular & hematological agents in medicinal chemistry 20110701 |
| Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux. | Acute cardiac care 20110601 |
| Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. | Blood 20110505 |
| Extended-infusion eptifibatide to prevent stent thrombosis in a patient undergoing orthopedic surgery. | The Annals of pharmacotherapy 20110501 |
| Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke. | Journal of neurosurgery 20110401 |
| Induction of integrin β3 in PGE₂-stimulated adhesion of mastocytoma P-815 cells to the Arg-Gly-Asp-enriched fragment of fibronectin. | Biochemical pharmacology 20110401 |
| Aortic root and valve thrombosis after implantation of a left ventricular assist device. | The Journal of invasive cardiology 20110401 |
| Pharmacotherapy: NSTE ACS--benefit of concomitant eptifibatide and clopidogrel use before angiography? | Nature reviews. Cardiology 20110401 |
| Update on glycoprotein IIb/IIIa: role in primary coronary intervention. | Cardiovascular & hematological agents in medicinal chemistry 20110401 |
| Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study. | Heart and vessels 20110301 |
| Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial. | Circulation 20110222 |
| Intracoronary delivery of eptifibatide with the ClearWay® RX infusion catheter. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20110201 |
| The impact and management of acquired platelet dysfunction. | Hamostaseologie 20110201 |
| Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. | Biomarkers in medicine 20110201 |
| Risk scores for patients with chest pain: evaluation in the emergency department. | Current cardiology reviews 20110201 |
| Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. | Circulation 20110125 |
| Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. | The American journal of cardiology 20110115 |
| Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention. | Journal of cardiovascular medicine (Hagerstown, Md.) 20110101 |
| Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide. | Resuscitation 20110101 |
| A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits. | Platelets 20110101 |
| Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation. | Journal of molecular recognition : JMR 20110101 |
| Atherosclerosis and thrombosis: insights from large animal models. | Journal of biomedicine & biotechnology 20110101 |
| Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal. | Frontiers in neurology 20110101 |
| Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. | Cardiology 20110101 |
| The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel. | Thrombosis journal 20110101 |
| Variations on fibrinogen-erythrocyte interactions during cell aging. | PloS one 20110101 |
| Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia. | Texas Heart Institute journal 20110101 |
| Integrin targeted therapeutics. | Theranostics 20110101 |
| Case of 'slow' stroke from carotid artery occlusion treated by delayed but cautious endovascular intervention. | Stroke research and treatment 20110101 |
| Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis. | PloS one 20110101 |
| Endovascular implantation of covered stents in the extracranial carotid and vertebral arteries: Case series and review of the literature. | Surgical neurology international 20110101 |
| Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. | International journal of vascular medicine 20110101 |
| Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview. | Vascular health and risk management 20110101 |
| Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? | International journal of vascular medicine 20110101 |
| Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention. | Vascular health and risk management 20110101 |
| The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. | PloS one 20110101 |
| The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. | Critical reviews in eukaryotic gene expression 20110101 |
| Emerging therapies for acute coronary syndromes. | Frontiers in pharmacology 20110101 |
| Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation. | BMC systems biology 20110101 |
| Novel agents for anti-platelet therapy. | Journal of hematology & oncology 20110101 |
| Coronary perforation and covered stents: an update and review. | Heart views : the official journal of the Gulf Heart Association 20110101 |
| Severe thrombocytopenia following tirofiban infusion. | Indian journal of pharmacology 20110101 |
| [Percutaneous coronary angioplasty in women: clinical, procedural and prognostic features]. | The Pan African medical journal 20110101 |
| Critical appraisal of ticagrelor in the management of acute coronary syndrome. | Therapeutics and clinical risk management 20110101 |
| Electron transfer dissociation coupled to an Orbitrap analyzer may promise a straightforward and accurate sequencing of disulfide-bridged cyclic peptides: a case study. | Journal of mass spectrometry : JMS 20101201 |
| The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. | JACC. Cardiovascular interventions 20101201 |
| Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide. | Folia histochemica et cytobiologica 20101201 |
| [Antiplatelet therapy in acute coronary syndromes: state of the art and new perspectives]. | Giornale italiano di cardiologia (2006) 20101201 |
| Review of Currently Available GP IIb/IIIa Inhibitors and Their Role in Peripheral Vascular Interventions. | Seminars in interventional radiology 20101201 |
| Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. | Blood 20101125 |
| Laser-induced endothelial cell activation supports fibrin formation. | Blood 20101125 |
| Dynamic regulation of fibrinogen: integrin αIIbβ3 binding. | Biochemistry 20101102 |
| Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. | Intensive care medicine 20101101 |
| Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor. | Journal of Korean medical science 20101101 |
| Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention. | Clinical cardiology 20101101 |
| Perspective on coronary interventions & cardiac surgeries in India. | The Indian journal of medical research 20101101 |
| Snake venom disintegrins and cell migration. | Toxins 20101101 |
| Making the right choice: optimizing rt-PA and eptifibatide lysis, an in vitro study. | Thrombosis research 20101001 |
| Comparison of immediate vs early invasive strategy in patients with first acute non-ST-elevation myocardial infarction. | Clinical cardiology 20101001 |
| Eptifibatide is noninferior to abciximab: implications for clinical practice. | Nature reviews. Cardiology 20101001 |
| The role of proteomics in depression research. | European archives of psychiatry and clinical neuroscience 20100901 |
| Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. | ACS nano 20100824 |
| Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial. | Journal of the American College of Cardiology 20100803 |
| Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). | Journal of the American College of Cardiology 20100803 |
| Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. | Journal of thrombosis and thrombolysis 20100801 |
| Vascular insights into the treatment of acute myocardial infarction by post-mortem in situ microcomputed tomography and histology. | European heart journal 20100801 |
| Improved liquid chromatography-tandem mass spectrometry method for the analysis of eptifibatide in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100801 |
| Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy. | The Journal of invasive cardiology 20100801 |
| Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. | JACC. Cardiovascular interventions 20100801 |
| Bivalirudin in acute myocardial infarction: 'primum non nocere': the eternal dilemma: balancing risks and benefits in high-risk patients. | JACC. Cardiovascular interventions 20100801 |
| Comparison by meta-analysis of eptifibatide and tirofiban to abciximab in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. | The American journal of cardiology 20100715 |
| Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy). | The American journal of cardiology 20100715 |
| What goes into a major acute coronary syndrome trial and what will future trials look like? | Current cardiology reports 20100701 |
| Percutaneous cardiopulmonary support in refractory no-reflow with cardiogenic shock after coronary stenting in acute myocardial infarction. | Yonsei medical journal 20100701 |
| Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. | European heart journal 20100701 |
| Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics. | Clinical research in cardiology : official journal of the German Cardiac Society 20100601 |
| Anesthetic concerns for patients with coagulopathy. | Current opinion in anaesthesiology 20100601 |
| Early administration of small-molecule glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from randomized clinical trials. | Journal of cardiovascular pharmacology and therapeutics 20100601 |
| Update on antithrombotic therapy for stroke prevention in atrial fibrillation. | Current treatment options in cardiovascular medicine 20100601 |
| The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study. | The Korean journal of internal medicine 20100601 |
| Acute profound thrombocytopenia following eptifibatide administration. | Southern medical journal 20100601 |
| Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms. | Journal of neurointerventional surgery 20100601 |
| Combined mechanical and pharmacological approach to a thrombus-containing lesion. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20100501 |
| Quantitative determination of oxytocin receptor antagonist atosiban in rat plasma by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100501 |
| Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach. | Journal of thrombosis and thrombolysis 20100401 |
| Thromboembolic events associated with Neuroform stent in endovascular treatment of intracranial aneurysms. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20100401 |
| Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature. | Pharmacotherapy 20100401 |
| RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation. | Journal of thrombosis and haemostasis : JTH 20100301 |
| Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial. | Circulation 20100216 |
| Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway? | Circulation 20100216 |
| [The EARLY ACS study]. | Giornale italiano di cardiologia (2006) 20100201 |
| [Don't throw the baby out with the bathwater. Treatment of acute coronary syndrome]. | Giornale italiano di cardiologia (2006) 20100201 |
| Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. | Thrombosis research 20100101 |
| Platelet thrombin receptor antagonism and atherothrombosis. | European heart journal 20100101 |
| Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions. | Platelets 20100101 |
| A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program. | Trials 20100101 |
| Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. | Thrombosis and haemostasis 20100101 |
| The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations. | Platelets 20100101 |
| Emergency neurological care of strokes and bleeds. | Journal of emergencies, trauma, and shock 20100101 |
| In-stent thrombosis after 68 months of implantation inspite of continuous dual antiplatelet therapy: a case report. | Cases journal 20100101 |
| Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. | BMC cardiovascular disorders 20100101 |
| Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention. | Vascular health and risk management 20100101 |
| Acute transient phlebitis during eptifibatide intravenous injection: case report. | Heart & lung : the journal of critical care 20100101 |
| Unusual towering elevation of troponin I after ST-elevation myocardial infarction and intensive monitoring with echocardiography post-percutaneous coronary intervention: a case report. | Journal of medical case reports 20100101 |
| Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. | Biomarker insights 20100101 |
| Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations. | Indian journal of anaesthesia 20100101 |
| Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor. | Vascular health and risk management 20100101 |
| Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis. | BMC medicine 20100101 |
| Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report. | Case reports in medicine 20100101 |
| Acute chest pain: Acute coronary syndrome versus lead perforation: A case report. | International archives of medicine 20100101 |
| Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin. | The open cardiovascular medicine journal 20100101 |
| Left ventricular rupture due to HIV-associated T-cell lymphoma. | Texas Heart Institute journal 20100101 |
| Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome. | Drug design, development and therapy 20100101 |
| GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin. | The open cardiovascular medicine journal 20100101 |
| Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. | Vascular health and risk management 20100101 |
| Characterization of human platelet binding of recombinant T cell receptor ligand. | Journal of neuroinflammation 20100101 |
| Assessment of eptifibatide clearance by hemodialysis using an in vitro system. | Blood purification 20100101 |
| The effect of tobacco smoking and treatment strategy on the one-year mortality of patients with acute non-ST-segment elevation myocardial infarction. | BMC cardiovascular disorders 20100101 |
| Primary PCI for acute anterior wall MI with pulmonary edema and left anterior descending artery ostial stenosis. | Indian heart journal 20100101 |
| Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier? | Stroke research and treatment 20100101 |
| Targeting the platelet integrin GPIIb/IIIa. | Current pharmaceutical design 20100101 |
| Newer antithrombotic drugs. | Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20100101 |
| Profound thrombocytopenia after primary exposure to eptifibatide. | Drug, healthcare and patient safety 20100101 |
| Structure and function of snake venom proteins affecting platelet plug formation. | Toxins 20100101 |
| Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. | JAMA 20091209 |
| Impact of computerized dosing on eptifibatide-associated bleeding and mortality. | American heart journal 20091201 |
| The GPIIbIIIa antagonist drugs eptifibatide and tirofiban do not induce activation of apoptosis executioner caspase-3 in resting platelets but inhibit caspase-3 activation in platelets stimulated with thrombin or calcium ionophore A23187. | Haematologica 20091201 |
| The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation. | Korean circulation journal 20091201 |
| Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study. | Journal of thrombosis and thrombolysis 20091101 |
| Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. | Neurosurgery 20091101 |
| Safety of eptifibatide for subcortical stroke progression. | Cerebrovascular diseases (Basel, Switzerland) 20091101 |
| Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. | European heart journal 20091101 |
| Glycoprotein IIb/IIIa antagonists: new developments. | Hamostaseologie 20091101 |
| [Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation - report of 2 cases]. | Kardiologia polska 20091101 |
| Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20091001 |
| Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. | Stroke 20091001 |
| Complications and controversies of regional anaesthesia: a review. | Indian journal of anaesthesia 20091001 |
| Integrin priming dynamics: mechanisms of integrin antagonist-promoted alphaIIbbeta3:PAC-1 molecular recognition. | Biochemistry 20090908 |
| Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial. | Lancet (London, England) 20090905 |
| Considering usual medical care in clinical trial design. | PLoS medicine 20090901 |
| Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia. | Blood 20090806 |
| Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study. | The Canadian journal of cardiology 20090801 |
| Balancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome. | The western journal of emergency medicine 20090801 |
| Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST). | Circulation. Cardiovascular interventions 20090801 |
| Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency. | Journal of thrombosis and thrombolysis 20090701 |
| Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature. | Pharmacotherapy 20090701 |
| Binding of plasma factor XIII to thrombin-receptor activated human platelets. | Thrombosis and haemostasis 20090701 |
| Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis). | The American journal of cardiology 20090701 |
| Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. | The American journal of emergency medicine 20090701 |
| Effect of left ventricular hypertrophy on long-term survival of patients with coronary artery disease following percutaneous coronary intervention. | Heart international 20090630 |
| Hotline sessions presented at the American College of Cardiology Congress 2009. | Clinical research in cardiology : official journal of the German Cardiac Society 20090601 |
| Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. | The Journal of invasive cardiology 20090601 |
| Provisional use of glycoprotein IIb/IIIa inhibitors in the era of dual antiplatelet therapy--do 'bailouts' pay off? | The Journal of invasive cardiology 20090601 |
| Variability of platelet aggregate dispersal with glycoprotein IIb-IIIa antagonists eptifibatide and abciximab. | Journal of thrombosis and haemostasis : JTH 20090601 |
| A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. | Circulation. Cardiovascular interventions 20090601 |
| Switch from abciximab to eptifibatide during percutaneous coronary intervention. | International journal of cardiology 20090529 |
| Early versus delayed, provisional eptifibatide in acute coronary syndromes. | The New England journal of medicine 20090521 |
| Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. | Journal of the American College of Cardiology 20090505 |
| The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? | Journal of the American College of Cardiology 20090505 |
| Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. | Diabetes care 20090501 |
| Adjunctive intracoronary antithrombotic therapy: time to revisit an old strategy? | The Journal of invasive cardiology 20090501 |
| Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. | Expert reviews in molecular medicine 20090501 |
| Point-of-care assessment of antiplatelet agents in the perioperative period: a review. | Anaesthesia and intensive care 20090501 |
| Perioperative management of antiplatelet-drugs in cardiac surgery. | Current cardiology reviews 20090501 |
| Empty microcatheter technique for the deployment of a self-expanding stent to treat refractory middle cerebral artery occlusion in the setting of severe proximal tortuosity. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20090401 |
| Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines. | International journal of clinical practice 20090401 |
| Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions. | Diabetes care 20090401 |
| Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes. | The Annals of pharmacotherapy 20090401 |
| Spontaneous coronary artery dissection and severe hypothyroidism. | The Journal of invasive cardiology 20090401 |
| Adjunctive Pharmacotherapy Part II. | The Journal of invasive cardiology 20090401 |
| Characterization of static adhesion of human platelets in plasma to protein surfaces in microplates. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20090401 |
| Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. | Journal of the American College of Cardiology 20090310 |
| Optimal antiplatelet therapy during percutaneous coronary interventions includes glycoprotein IIb/IIIa inhibitors just eliminate the infusion. | Journal of the American College of Cardiology 20090310 |
| Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. | The Journal of clinical investigation 20090302 |
| Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation. | Coronary artery disease 20090301 |
| Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention. | The Journal of invasive cardiology 20090301 |
| Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time. | The Journal of invasive cardiology 20090301 |
| Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation. | Thrombosis and haemostasis 20090301 |
| Prevention and treatment of thromboembolism during endovascular aneurysm therapy. | Klinische Neuroradiologie 20090301 |
| Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study. | Journal of the American College of Cardiology 20090224 |
| Determination of eptifibatide concentration in human plasma utilizing the liquid chromatography-tandem mass spectrometry method. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090215 |
| Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome. | Journal of thrombosis and thrombolysis 20090201 |
| Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090201 |
| The benefits and risks of abciximab, eptifibatide, or tirofiban during PCI: class effects or do they differ? | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090201 |
| Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction. | Platelets 20090201 |
| Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial. | Circulation. Cardiovascular interventions 20090201 |
| Eptifibatide overdose. | International journal of cardiology 20090124 |
| Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. | Blood 20090122 |
| Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots. | Thrombosis research 20090101 |
| Analysis of adenoviral attachment to human platelets. | Virology journal 20090101 |
| Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? | Thrombosis journal 20090101 |
| Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization. | Vascular health and risk management 20090101 |
| Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. | Vascular health and risk management 20090101 |
| Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention. | Texas Heart Institute journal 20090101 |
| Clopidogrel resistance 'Live' - the risk of stent thrombosis should be evaluated before procedures. | Thrombosis journal 20090101 |
| The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. | Acta poloniae pharmaceutica 20090101 |
| Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention. | Vascular health and risk management 20090101 |
| Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. | Scandinavian journal of trauma, resuscitation and emergency medicine 20090101 |
| Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. | Trials 20090101 |
| A retrospective analysis and case series of glycoprotein IIb/IIIa inhibitor associated diffuse alveolar hemorrhage: two case reports. | Cases journal 20090101 |
| Antiplatelet drugs and the perioperative period: What every urologist needs to know. | Indian journal of urology : IJU : journal of the Urological Society of India 20090101 |
| The roles of platelet GPIIb/IIIa and alphavbeta3 integrins during HeLa cells adhesion, migration, and invasion to monolayer endothelium under static and dynamic shear flow. | Journal of biomedicine & biotechnology 20090101 |
| Drug-induced hematologic syndromes. | Advances in hematology 20090101 |
| Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. | Hematology. American Society of Hematology. Education Program 20090101 |
| An unusual case of spontaneous multi vessel coronary artery dissection in an elderly patient: a case report. | Cases journal 20090101 |
| Is anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics. | Journal of Indian Society of Periodontology 20090101 |
| Antiplatelet Resistance-Does it Exist and How to Measure it? | Clinical medicine. Cardiology 20090101 |
| Acute coronary syndrome in pregnancy. | Clinical medicine. Cardiology 20090101 |
| Eptifibatide: The evidence for its role in the management of acute coronary syndromes. | Core evidence 20090101 |
| Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. | Heart (British Cardiac Society) 20081201 |
| The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. | Stroke 20081201 |
| Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20081201 |
| The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome. | Journal of interventional cardiology 20081201 |
| The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy. | JACC. Cardiovascular interventions 20081201 |
| The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary. | Current cardiology reviews 20081101 |
| Rescue treatment with intra-arterial tirofiban infusion and emergent carotid stenting. | Yonsei medical journal 20081031 |
| Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20081001 |
| Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study. | Thrombosis and haemostasis 20081001 |
| Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial. | American heart journal 20081001 |
| A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. | Journal of cardiovascular medicine (Hagerstown, Md.) 20080901 |
| GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: new trial and registry data. | Current cardiology reports 20080901 |
| Bolus-only versus bolus + infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. | American heart journal 20080901 |
| Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab. | The Korean journal of internal medicine 20080901 |
| Local intra-arterial eptifibatide for intraoperative vessel thrombosis during aneurysm coiling. | AJNR. American journal of neuroradiology 20080801 |
| A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention. | Yonsei medical journal 20080630 |
| Treatment-competing events in dynamic regimes. | Lifetime data analysis 20080601 |
| Functional and computational studies of the ligand-associated metal binding site of beta3 integrins. | Proteins 20080601 |
| In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus. | Coronary artery disease 20080601 |
| Utilization of GP IIb/IIIa inhibitors in peripheral percutaneous interventions: current applications and in-hospital outcomes at a tertiary referral center. | The Journal of invasive cardiology 20080601 |
| Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin. | Vascular health and risk management 20080601 |
| Antiplatelet drugs in cardiological practice: established strategies and new developments. | Vascular health and risk management 20080601 |
| Pharmacological and mechanical revascularization strategies in STEMI: integration of the two approaches. | The Journal of invasive cardiology 20080501 |
| Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel. | The Journal of invasive cardiology 20080501 |
| The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept? | Current cardiology reviews 20080501 |
| Eptifibatide-induced thrombocytopenia. | Journal of thrombosis and thrombolysis 20080401 |
| Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. | Neuroradiology 20080401 |
| Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. | Journal of interventional cardiology 20080401 |
| Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. | The Journal of invasive cardiology 20080301 |
| Abciximab: a reappraisal of its use in coronary care. | Biologics : targets & therapy 20080301 |
| Rescue use of tirofiban for acute carotid in-stent thrombosis. | Yonsei medical journal 20080227 |
| The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. | Journal of the American College of Cardiology 20080205 |
| The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide. | Journal of the American College of Cardiology 20080205 |
| Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen. | Blood 20080201 |
| High-dose tirofiban administered as bolus-only during percutaneous coronary intervention. | The Journal of invasive cardiology 20080201 |
| ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. | The American journal of emergency medicine 20080201 |
| [Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management]. | Giornale italiano di cardiologia (2006) 20080201 |
| A review of cardiogenic shock in acute myocardial infarction. | Current cardiology reviews 20080201 |
| Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors. | International journal of cardiology 20080124 |
| Complications of Neuroform stent in endovascular treatment of intracranial aneurysms. | Neurocritical care 20080101 |
| Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20080101 |
| Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease. | Current vascular pharmacology 20080101 |
| The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. | PPAR research 20080101 |
| Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia. | Thrombosis research 20080101 |
| Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions. | Drugs 20080101 |
| A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101 |
| Glycoprotein IIb/IIIa inhibitors in patients with renal insufficiency undergoing percutaneous coronary intervention. | Cardiology in review 20080101 |
| Diagnostic uncertainty of Takotusbo cardiomyopathy in a woman with cardiovascular risk factors hijacked at gunpoint: a case report. | Cases journal 20080101 |
| Plateletworks: a novel point of care platelet function screen. | Molecular diagnosis & therapy 20080101 |
| Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. | Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20080101 |
| Successful catheter ablation of persistent electrical storm late post myocardial infarction by targeting purkinje arborization triggers. | Indian pacing and electrophysiology journal 20080101 |
| Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: rationale and design of the Sonolysis study. | Trials 20080101 |
| Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells. | Cardiovascular diabetology 20080101 |
| Phase I study of eptifibatide in patients with sickle cell anaemia. | British journal of haematology 20071101 |
| Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention. | The American journal of cardiology 20071101 |
| Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists. | Platelets 20071101 |
| Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). | Clinical research in cardiology : official journal of the German Cardiac Society 20071001 |
| Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial). | The American journal of cardiology 20071001 |
| Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention. | The Canadian journal of cardiology 20071001 |
| [Massive pulmonary embolism mimicking ST-elevation acute coronary syndrome successfully treated with hybrid therapy in a trauma patient receiving nadroparin: diagnostic and therapeutic dilemmas]. | Kardiologia polska 20071001 |
| Beta2-integrins and acquired glycoprotein IIb/IIIa (GPIIb/IIIa) receptors cooperate in NF-kappaB activation of human neutrophils. | The Journal of biological chemistry 20070921 |
| Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. | Journal of managed care pharmacy : JMCP 20070901 |
| Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. | Arteriosclerosis, thrombosis, and vascular biology 20070801 |
| Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study. | American heart journal 20070801 |
| Immediate and intermediate results of intracoronary stand-alone bolus administration of eptifibatide during coronary intervention (ICE) study. | American heart journal 20070801 |
| A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20070801 |
| Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20070701 |
| Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction. | The American journal of cardiology 20070701 |
| Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis). | The American journal of cardiology 20070615 |
| Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention. | Journal of the American College of Cardiology 20070605 |
| The role of eptifibatide in patients undergoing percutaneous coronary intervention. | Expert opinion on pharmacotherapy 20070601 |
| The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT. | Biologics : targets & therapy 20070601 |
| Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). | The American journal of cardiology 20070515 |
| Present and evolving role of eptifibatide in the treatment of acute coronary syndromes. | Expert review of cardiovascular therapy 20070501 |
| Middle cerebral artery stenting for acute ischemic stroke after unsuccessful Merci retrieval. | Neurosurgery 20070401 |
| Current strategies with high-dose tirofiban. | Expert opinion on drug metabolism & toxicology 20070401 |
| Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome. | Vascular health and risk management 20070401 |
| AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists. | Journal of thrombosis and haemostasis : JTH 20070301 |
| Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction. | Coronary artery disease 20070301 |
| Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass. | Journal of cardiovascular pharmacology and therapeutics 20070301 |
| Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? | Journal of the American College of Cardiology 20070213 |
| [Update on antithrombotic treatments in arterial diseases]. | Revue medicale suisse 20070207 |
| Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results. | The Journal of invasive cardiology 20070201 |
| Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction. | Mayo Clinic proceedings 20070201 |
| Prolonged intravenous eptifibatide infusion for prevention of coronary stent thrombosis. | International journal of cardiology 20070118 |
| Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions. | Cardiology 20070101 |
| Rapid disappearance of an endothelial ulceration in the left main coronary artery. | Cardiology 20070101 |
| Role of antiplatelets in carotid artery stenting. | Stroke 20070101 |
| The integrins. | Genome biology 20070101 |
| Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro. | Clinical chemistry and laboratory medicine 20070101 |
| Systemic reperfusion therapy in acute ischemic stroke. | Cerebrovascular diseases (Basel, Switzerland) 20070101 |
| A review of clinical trials with eptifibatide in cardiology. | Cardiovascular drug reviews 20070101 |
| [Von Willebrand factor and soluble P-selectin in patients with non ST-Elevation acute coronary syndrome during treatment with glycoprotein IIb/IIIa antagonist eptifibatide]. | Kardiologiia 20070101 |
| Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. | Journal of the American College of Cardiology 20061205 |
| Delayed profound thrombocytopenia associated with eptifibatide. | American journal of hematology 20061201 |
| Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results. | Journal of cardiovascular medicine (Hagerstown, Md.) 20061201 |
| Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. | Thrombosis and haemostasis 20061201 |
| PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. | The Journal of invasive cardiology 20061201 |
| Bivalirudin in percutaneous coronary intervention. | Vascular health and risk management 20061201 |
| Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). | Vascular health and risk management 20061201 |
| [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation]. | Deutsche medizinische Wochenschrift (1946) 20061124 |
| Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention. | The Journal of invasive cardiology 20061101 |
| Bolus-only glycoprotein IIb/IIIa inhibitor revisited. | The Journal of invasive cardiology 20061101 |
| Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. | American heart journal 20061001 |
| Unfractionated heparin reduces the anti-platelet effects of abciximab but not eptifibatide during PCI. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20061001 |
| Eptifibatide-induced thrombocytopenia and thrombosis. | Journal of thrombosis and thrombolysis 20061001 |
| Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms. | AJNR. American journal of neuroradiology 20061001 |
| High-dose, single-bolus eptifibatide: a safe and cost-effective alternative to conventional glycoprotein IIb/IIIa inhibitor use for elective coronary interventions. | The Journal of invasive cardiology 20061001 |
| Commentary: Alternative safe, effective and cost-efficient dosing for eptifibatide in low-risk patients. | The Journal of invasive cardiology 20061001 |
| [Platelet and tissue factor: review]. | Zhongguo shi yan xue ye xue za zhi 20061001 |
| Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. | Circulation 20060926 |
| Role of abciximab in the treatment of coronary artery disease. | Expert opinion on biological therapy 20060901 |
| Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation. | The Journal of invasive cardiology 20060901 |
| Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20060801 |
| Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. | Journal of thrombosis and thrombolysis 20060801 |
| C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. | British journal of haematology 20060801 |
| Complementary effects of sirolimus-eluting stents and glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention in diabetic patients: one-year follow up of a single-centre registry. | Heart (British Cardiac Society) 20060801 |
| Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibitide on thrombin-induced platelet activation. | Coronary artery disease 20060801 |
| Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. | Journal of interventional cardiology 20060801 |
| Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. | Circulation research 20060707 |
| In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters. | Life sciences 20060620 |
| A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. | Journal of the American College of Cardiology 20060620 |
| Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. | Journal of the American College of Cardiology 20060620 |
| The future of an illusion. | Journal of the American College of Cardiology 20060620 |
| Self-expanding stent-assisted middle cerebral artery recanalization: technical note. | Neuroradiology 20060601 |
| Anticoagulant and antiplatelet medications. | Critical care nurse 20060601 |
| Cold leg in patient with high coated platelets: possible association with the use of rofecoxib. | The Journal of invasive cardiology 20060601 |
| Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. | The American journal of cardiology 20060515 |
| Cost-effectiveness analysis of antithrombotic therapy in nonurgent percutaneous coronary intervention. | Pharmacotherapy 20060501 |
| [Acute coronary syndrome: peri-interventional antithrombotic therapy]. | Hamostaseologie 20060501 |
| Suspected clopidogrel resistance in a patient with acute stent thrombosis. | Nature clinical practice. Cardiovascular medicine 20060401 |
| Treating the acute stroke patient as an emergency: current practices and future opportunities. | International journal of clinical practice 20060401 |
| (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets. | Journal of thrombosis and haemostasis : JTH 20060401 |
| Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model. | The Thoracic and cardiovascular surgeon 20060401 |
| Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. | Journal of thrombosis and haemostasis : JTH 20060301 |
| Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia. | Pharmacotherapy 20060301 |
| Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. | Thrombosis and haemostasis 20060301 |
| Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. | Thrombosis and haemostasis 20060301 |
| Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? | Vascular health and risk management 20060301 |
| Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial. | Journal of the American College of Cardiology 20060221 |
| The value of selectivity. | Journal of the American College of Cardiology 20060221 |
| Variability in extent of platelet function inhibition after administration of optimal dose of glycoprotein IIb/IIIa receptor blockers in patients undergoing a high-risk percutaneous coronary intervention. | The American journal of cardiology 20060215 |
| The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis. | Journal of the American College of Cardiology 20060207 |
| Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction. | Journal of the American College of Cardiology 20060207 |
| Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus. | Coronary artery disease 20060201 |
| Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists. | The American journal of cardiology 20060201 |
| Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial. | American heart journal 20060201 |
| Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction. | The Journal of invasive cardiology 20060201 |
| Recurrent acute profound thrombocytopenia related to readministration of eptifibatide. | Journal of interventional cardiology 20060201 |
| Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists. | Thrombosis research 20060101 |
| Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin. | Thrombosis research 20060101 |
| Tirofiban for the treatment of ischaemic stroke. | Expert opinion on pharmacotherapy 20060101 |
| Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial. | The Journal of invasive cardiology 20060101 |
| Thrombosis, inflammation, and our evolving understanding of vascular biology during interventional therapy. | The Journal of invasive cardiology 20060101 |
| Platelet receptors. | AJNR. American journal of neuroradiology 20060101 |
| Spotlight on eptifibatide in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20060101 |
| [Glycoprotein IIb/IIIa antagonist eptifibatide in acute coronary syndrome without elevation of ST segment]. | Kardiologiia 20060101 |
| Acute ischemic heart disease and interventional cardiology: a time for pause. | BMC medicine 20060101 |
| An audit of the use and complications of glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention against national UK standards. | Cardiovascular revascularization medicine : including molecular interventions 20060101 |
| A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. | PloS one 20060101 |
| Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function. | Reviews in cardiovascular medicine 20060101 |
| Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trial. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20051201 |
| Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. | The American journal of cardiology 20051201 |
| Successful management of the no-reflow syndome after venous graft stenting. | The Journal of invasive cardiology 20051201 |
| Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes. | Expert opinion on drug metabolism & toxicology 20051201 |
| Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. | European heart journal 20051001 |
| Outcomes and costs of abciximab versus eptifibatide for percutaneous coronary intervention. | The Annals of pharmacotherapy 20051001 |
| Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20051001 |
| Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists. | Thrombosis and haemostasis 20051001 |
| The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention. | Coronary artery disease 20050901 |
| Pharmacologic cerebral capillary blood flow improvement after deep hypothermic circulatory arrest: an intravital fluorescence microscopy study in pigs. | The Journal of thoracic and cardiovascular surgery 20050901 |
| Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). | The American journal of cardiology 20050815 |
| The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used. | Journal of thrombosis and thrombolysis 20050801 |
| Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. | The Journal of biological chemistry 20050701 |
| Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen. | Journal of cardiovascular pharmacology 20050701 |
| Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050701 |
| Direct thrombin inhibitors. | Current cardiology reports 20050701 |
| Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial. | The Journal of invasive cardiology 20050701 |
| Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. | American heart journal 20050701 |
| Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. | Thrombosis and haemostasis 20050701 |
| Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide? | Nature clinical practice. Cardiovascular medicine 20050701 |
| Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel with or without INtegrilin [DEACON] study). | The American journal of cardiology 20050615 |
| Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial). | The American journal of cardiology 20050601 |
| Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. | Journal of cardiovascular electrophysiology 20050601 |
| The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale. | American heart journal 20050601 |
| The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. | The Journal of invasive cardiology 20050601 |
| Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. | The Journal of invasive cardiology 20050601 |
| Use of antiplatelet inhibitors in peripheral vascular interventions. | Seminars in interventional radiology 20050601 |
| Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180. | The Biochemical journal 20050401 |
| Hypothermia-induced platelet aggregation: no effect of aprotinin (trasylol) but inhibition by eptifibatide (integrilin). | The Thoracic and cardiovascular surgeon 20050401 |
| Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in? | Pharmacy world & science : PWS 20050401 |
| Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trial. | American heart journal 20050401 |
| Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. | Circulation 20050308 |
| Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. | Circulation 20050308 |
| Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). | The American journal of cardiology 20050301 |
| Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). | The American journal of cardiology 20050301 |
| Safety of coronary stenting with eptifibatide and ultra-low-dose heparin. | The American journal of cardiology 20050301 |
| Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide. | Transfusion 20050301 |
| Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors? | The journal of extra-corporeal technology 20050301 |
| Eptifibatide-associated acute, profound thrombocytopenia. | The Annals of pharmacotherapy 20050201 |
| GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. | Journal of thrombosis and haemostasis : JTH 20050201 |
| Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. | Chest 20050201 |
| In vivo platelet redistribution and acute transient thrombocytopenia after eptifibatide injection in baboons. | Thrombosis research 20050101 |
| Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy. | Neurosurgery 20050101 |
| Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. | American heart journal 20050101 |
| Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection. | Drugs 20050101 |
| Calpha-H...O = C hydrogen bonds contribute to the specificity of RGD cell-adhesion interactions. | BMC structural biology 20050101 |
| Functional characteristic of snake venom disintegrins: potential therapeutic implication. | Current pharmaceutical design 20050101 |
| Medical decision making with incomplete evidence--choosing a platelet glycoprotein IIbIIIa receptor inhibitor for percutaneous coronary interventions. | Medical decision making : an international journal of the Society for Medical Decision Making 20050101 |
| Profound thrombocytopenia associated with tirofiban: case report and review of literature. | Angiology 20050101 |
| The impact of adjunctive eptifibatide therapy with percutaneous coronary intervention for acute myocardial infarction. | International journal of cardiovascular interventions 20050101 |
| Molecular aspects of thrombosis and antithrombotic drugs. | Critical reviews in clinical laboratory sciences 20050101 |
| Is platelet adhesion assay able to quantify drug-induced platelet dysfunction? | Seminars in thrombosis and hemostasis 20050101 |
| Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents. | Seminars in thrombosis and hemostasis 20050101 |
| Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much? | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. | Drugs 20050101 |
| The role of the platelet in the pathogenesis of atherothrombosis. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Equipoise in the enhanced supression of the platelet IIb/IIIa receptor with integrilin trial (ESPRIT): a critical appraisal. | Clinical trials (London, England) 20050101 |
| Effects of three groin compression methods on patient discomfort, distress, and vascular complications following a percutaneous coronary intervention procedure. | Nursing research 20050101 |
| Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy. | Cardiovascular revascularization medicine : including molecular interventions 20050101 |
| Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina. | Thrombosis journal 20050101 |
| Inhibition of platelet activation and aggregation. | Handbook of experimental pharmacology 20050101 |
| Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes. | The Annals of pharmacotherapy 20041201 |
| A novel method to assess platelet inhibition by eptifibatide with thrombelastograph. | Anesthesia and analgesia 20041201 |
| Effect of bivalirudin on length of stay in the recovery area after percutaneous coronary intervention compared with heparin alone, heparin + abciximab, or heparin + eptifibatide. | The American journal of cardiology 20041201 |
| Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? | Journal of clinical pharmacy and therapeutics 20041201 |
| Soluble CD40 ligand is an early initiator of inflammation after coronary intervention. | Coronary artery disease 20041201 |
| Rescue in situ thrombolysis for acute coronary thromboembolism in an angiographically normal coronary artery. | Saudi medical journal 20041201 |
| The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIB-IIIa antagonists. | Journal of thrombosis and thrombolysis 20041201 |
| Bootstrap confidence intervals for medical costs with censored observations. | Statistics in medicine 20041115 |
| Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effect of the -174 G/C IL-6 gene polymorphism. | The American journal of cardiology 20041115 |
| Evaluation of bleeding complications associated with glycoprotein IIb/IIIa inhibitors. | The Annals of pharmacotherapy 20041101 |
| Fibrinogen receptor antagonists induce conformational changes of the human platelet glycoprotein IIb. | Cytometry. Part B, Clinical cytometry 20041101 |
| Development of glycoprotein IIb-IIIa antagonists: translation of pharmacodynamic effects into clinical benefit. | Expert review of cardiovascular therapy 20041101 |
| Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions. | The Journal of invasive cardiology 20041101 |
| A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting. | The Canadian journal of cardiology 20041101 |
| [Eptifibatide and percutaneous coronary intervention]. | Herz 20041101 |
| [Eptifibatide in patients with percutaneous coronary intervention in clinical practice. Results of a prospective registry]. | Herz 20041101 |
| A case of life-saving pharmacologic and mechanical coronary dethrombosis. | Italian heart journal : official journal of the Italian Federation of Cardiology 20041101 |
| Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. | Cardiovascular drugs and therapy 20041101 |
| Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes. | JAMA 20041020 |
| Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. | Stroke 20041001 |
| Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). | The American journal of cardiology 20041001 |
| Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors. | Seminars in thrombosis and hemostasis 20041001 |
| Comparative pharmacodynamic evaluation of eptifibatide and abciximab in patients with non-ST-segment elevation acute coronary syndromes: the TAM2 study. | Journal of thrombosis and thrombolysis 20041001 |
| Platelet function predicts myocardial damage in patients with acute myocardial infarction. | Circulation 20040914 |
| Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention. | Journal of clinical pharmacology 20040901 |
| Spontaneous coronary artery dissection postpartum. | The Journal of invasive cardiology 20040901 |
| Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience. | The Journal of invasive cardiology 20040901 |
| Prehospital therapy with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide in patients with suspected acute coronary syndromes: the Bochum feasibility study. | Chest 20040901 |
| Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | Chest 20040901 |
| Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | Chest 20040901 |
| Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. | JAMA 20040811 |
| Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy. | Circulation 20040810 |
| Utilization of eptifibatide for treatment of severe dissections as a bail-out procedure. | International journal of cardiology 20040801 |
| Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients. | The Annals of thoracic surgery 20040801 |
| Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts and myocardial infarction. | American journal of hematology 20040801 |
| Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. | Journal of the American College of Cardiology 20040721 |
| Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention. | Heart (British Cardiac Society) 20040701 |
| Integrin clustering mechanisms explored with a soluble alphaIIbbeta3 ectodomain construct. | Biochimica et biophysica acta 20040701 |
| Platelet glycoprotein IIb/IIIa inhibition and its clinical use. | Current medicinal chemistry. Cardiovascular and hematological agents 20040701 |
| Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. | Circulation 20040629 |
| Clopidogrel resistance: a new chapter in a fast-moving story. | Circulation 20040629 |
| Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. | Journal of the American College of Cardiology 20040616 |
| Alveolar hemorrhage associated with periprocedural eptifibatide administration. | The Journal of invasive cardiology 20040601 |
| Angiographic demonstration of coronary dethrombosis with eptifibatide. | The Journal of invasive cardiology 20040601 |
| Effect of multielement intravascular ultrasound on the anticoagulant potency of enoxaparin. | The American journal of cardiology 20040601 |
| Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040601 |
| Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored. | Biometrics 20040601 |
| Six-month outcomes of percutaneous coronary balloon angioplasty in acute coronary syndromes: Results from the PURSUIT trial. | The Canadian journal of cardiology 20040601 |
| Change of care for patients with acute myocardial infarctions through algorithm and standardized physician order sets. | Critical pathways in cardiology 20040601 |
| Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study). | The American journal of cardiology 20040515 |
| Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions. | Coronary artery disease 20040501 |
| Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro. | The Journal of laboratory and clinical medicine 20040501 |
| Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. | American heart journal 20040501 |
| Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. | Journal of the American College of Cardiology 20040407 |
| Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial. | American heart journal 20040401 |
| Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era. | Journal of interventional cardiology 20040401 |
| Progress in the field of GPIIb/IIIa antagonists. | Current medicinal chemistry. Cardiovascular and hematological agents 20040401 |
| [Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice]. | Deutsche medizinische Wochenschrift (1946) 20040319 |
| Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation. | Journal of the American College of Cardiology 20040317 |
| Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61). | The Journal of pharmacology and experimental therapeutics 20040301 |
| Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. | Current hematology reports 20040301 |
| Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040301 |
| Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit. | Journal of cardiovascular pharmacology 20040301 |
| Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trials. | Current opinion in investigational drugs (London, England : 2000) 20040301 |
| Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040301 |
| Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function. | Clinical therapeutics 20040301 |
| Platelet glycoprotein IIb/IIIa inhibitors. | Best practice & research. Clinical haematology 20040301 |
| Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. | Journal of the American College of Cardiology 20040218 |
| Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention. | The American journal of cardiology 20040215 |
| Safety of high-dose intravenous eptifibatide as an adjunct to internal carotid artery angioplasty and stent placement: a prospective registry. | Neurosurgery 20040201 |
| GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040201 |
| Intracoronary coagulative nightmare during recanalization of a recent total occlusion of the left anterior descending artery. | The Journal of invasive cardiology 20040201 |
| Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. | Platelets 20040201 |
| Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery. | The Canadian journal of cardiology 20040201 |
| Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation. | Pharmacy world & science : PWS 20040201 |
| The efficacy and safety of perioperative antiplatelet therapy. | Journal of thrombosis and thrombolysis 20040201 |
| Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. | Journal of the American College of Cardiology 20040121 |
| Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury. | Journal of the American College of Cardiology 20040121 |
| Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes. | The American journal of medicine 20040115 |
| Role of platelet glycoprotein polymorphisms in cardiovascular diseases. | Naunyn-Schmiedeberg's archives of pharmacology 20040101 |
| Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. | American heart journal 20040101 |
| Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary intervention. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040101 |
| Eptifibatide and risk of bleeding after failed thrombolysis. | The Journal of invasive cardiology 20040101 |
| Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101 |
| A laboratory method for parallel determination of platelet aggregation and thrombin generation. | Clinical laboratory 20040101 |
| Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes. | Thrombosis research 20040101 |
| Hemorheological methods in drug research. | Clinical hemorheology and microcirculation 20040101 |
| Therapeutics of platelet glycoprotein IIb/IIIa receptor antagonism. | American journal of therapeutics 20040101 |
| Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. | Clinical pharmacokinetics 20040101 |
| Eptifibatide-induced profound thrombocytopenia. | Indian heart journal 20040101 |
| Dual coronary emboli in peripartum cardiomyopathy. | Texas Heart Institute journal 20040101 |
| Eptifibatide does not influence lymphocyte activation and CRP levels in patients with undergoing coronary angioplasty. | International journal of cardiovascular interventions 20040101 |
| Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. | Blood 20031215 |
| Characterization of eptifibatide during drug formulation stability assays. | Journal of pharmaceutical and biomedical analysis 20031204 |
| Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia. | Thrombosis and haemostasis 20031201 |
| Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes. | The American journal of medicine 20031201 |
| A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. | American heart journal 20031201 |
| Eptifibatide-induced thrombocytopenia and circulating procoagulant platelet-derived microparticles in a patient with acute coronary syndrome. | Journal of thrombosis and haemostasis : JTH 20031201 |
| The effects of aprotinin on platelet function in blood exposed to eptifibatide: an in vitro analysis. | The journal of extra-corporeal technology 20031201 |
| Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. | Circulation 20031125 |
| Using eptifibatide in patients undergoing coronary angioplasty with acute myocardial infarction. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20031101 |
| Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention. | The American journal of cardiology 20031101 |
| Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation. | The American journal of cardiology 20031101 |
| Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention. | American heart journal 20031101 |
| Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. | American heart journal 20031101 |
| [Platelet aggregation disorders]. | Hamostaseologie 20031101 |
| Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia. | The Journal of invasive cardiology 20031101 |
| Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. | Circulation 20031021 |
| Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. | American heart journal 20031001 |
| [Role of GP IIb/IIIa blockers in clinical cardiology]. | Recenti progressi in medicina 20031001 |
| Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin. | Clinical therapeutics 20031001 |
| Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. | Journal of thrombosis and haemostasis : JTH 20030901 |
| Low molecular weight heparins combined with platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes. | Expert opinion on investigational drugs 20030901 |
| Preservation of myocardial microcirculation during mechanical reperfusion for myocardial ischemia with either abciximab or eptifibatide. | The Journal of invasive cardiology 20030901 |
| Microcirculatory effects of abciximab and eptifibatide: a critical appraisal. | The Journal of invasive cardiology 20030901 |
| [Facilitated revascularisation in myocardial infarction with ST-segment elevation]. | Orvosi hetilap 20030810 |
| Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. | Journal of the American College of Cardiology 20030806 |
| Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. | Circulation 20030805 |
| Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists. | Coronary artery disease 20030801 |
| Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030801 |
| [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease]. | Herz 20030801 |
| Diminution in flow following primary stenting in the INAMI study. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030701 |
| Use of GPIIb/IIIa inhibitors in cardiovascular medicine. | Expert review of cardiovascular therapy 20030701 |
| Power calculations for large multi-arm placebo-controlled studies of dichotomous outcomes. | Statistics in medicine 20030630 |
| Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030615 |
| Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting. | The American journal of cardiology 20030601 |
| Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome. | The Annals of pharmacotherapy 20030601 |
| Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention. | The Journal of invasive cardiology 20030601 |
| Glycoprotein Wars and PIECE activists. | The Journal of invasive cardiology 20030601 |
| Acute thrombocytopenia associated with eptifibatide therapy. | The Canadian journal of cardiology 20030601 |
| Switching from abciximab to eptifibatide for percutaneous coronary interventions: a local analysis (SWAP study). | The Canadian journal of cardiology 20030601 |
| Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. | Journal of vascular and interventional radiology : JVIR 20030601 |
| Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis. | Journal of thrombosis and thrombolysis 20030601 |
| CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Circulation research 20030516 |
| [New anticoagulants]. | Nederlands tijdschrift voor geneeskunde 20030510 |
| Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment. | Heart (British Cardiac Society) 20030501 |
| GPIIb/IIIa antagonists and other anti-integrins. | Seminars in vascular medicine 20030501 |
| Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. | Journal of the American College of Cardiology 20030416 |
| A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. | The American journal of cardiology 20030415 |
| Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb/IIIa antagonists: potential rebound prothrombotic effect? | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030401 |
| Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. | Journal of cardiovascular pharmacology 20030401 |
| Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage. | The Journal of invasive cardiology 20030401 |
| [GP IIb/IIIa receptor prevention medicine]. | Nihon rinsho. Japanese journal of clinical medicine 20030401 |
| Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. | Journal of interventional cardiology 20030401 |
| Comparative pharmacology of GP IIb/IIIa antagonists. | Journal of thrombosis and thrombolysis 20030401 |
| Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. | Circulation 20030325 |
| Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. | Circulation 20030304 |
| Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. | Blood 20030301 |
| Comparison of shear stress-induced platelet microparticle formation and phosphatidylserine expression in presence of alphaIIbbeta3 antagonists. | Journal of cardiovascular pharmacology 20030301 |
| Acute profound thrombocytopenia associated with eptifibatide therapy. | Pharmacotherapy 20030301 |
| Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing. | Zeitschrift fur Kardiologie 20030301 |
| [Costs and cost-effectiveness of Eptifibatide in the treatment of coronary ischemic syndromes. An analysis based on the PURSUIT study]. | Zeitschrift fur Kardiologie 20030301 |
| Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. | JAMA 20030219 |
| Introduction to 'Optimizing management of non-ST-segment elevation acute coronary syndromes'. Harmonizing advances in mechanical and pharmacologic intervention. | Journal of the American College of Cardiology 20030219 |
| Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial. | Journal of the American College of Cardiology 20030219 |
| Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors. | Blood 20030215 |
| Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention. | The American journal of cardiology 20030215 |
| Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy. | The American journal of cardiology 20030215 |
| [Impact of GP IIb/IIIa antagonists in interventional cardiology]. | Deutsche medizinische Wochenschrift (1946) 20030207 |
| Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. | Journal of the American College of Cardiology 20030205 |
| Cost effectiveness in Canada of eptifibatide treatment for acute coronary syndrome patients using PURSUIT subgroup analysis. | The Canadian journal of cardiology 20030201 |
| Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process. | The Canadian journal of cardiology 20030201 |
| Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20030201 |
| Adjunctive use of platelet glycoprotein IIb/IIIa inhibitors for carotid angioplasty and stent placement: time to say good bye? | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 20030201 |
| Eptifibatide-induced thrombocytopenia and coronary bypass operation. | Journal of thrombosis and haemostasis : JTH 20030201 |
| Ligand binding promotes the entropy-driven oligomerization of integrin alpha IIb beta 3. | The Journal of biological chemistry 20030131 |
| Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. | Circulation 20030121 |
| Anti-integrin therapy. | Annual review of medicine 20030101 |
| Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). | The American journal of cardiology 20030101 |
| Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030101 |
| Acute profound thrombocytopenia after use of eptifibatide for coronary stenting. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030101 |
| Eptifibatide-induced acute profound thrombocytopenia presenting as refractory hypotension. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030101 |
| Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. | Journal of the American College of Cardiology 20030101 |
| Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. | Journal of the American College of Cardiology 20030101 |
| Open-label, sequential comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary intervention. | Clinical therapeutics 20030101 |
| [New antiaggregants and their importance for the practitioner]. | Therapeutische Umschau. Revue therapeutique 20030101 |
| Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. | Drugs 20030101 |
| Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. | Clinical pharmacokinetics 20030101 |
| Acute procedural complications and in-hospital events after percutaneous coronary interventions: eptifibatide versus abciximab. | Cardiovascular radiation medicine 20030101 |
| Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. | Expert opinion on drug safety 20030101 |
| Eptifibatide: a pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes. | PharmacoEconomics 20030101 |
| Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome. | Progress in cardiovascular nursing 20030101 |
| Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101 |
| Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101 |
| Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101 |
| [Safety and efficacy of ANGIOGUARD protection device for the prevention of distal embolization during PCI in patients with unstable angina]. | Przeglad lekarski 20030101 |
| Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. | Circulation 20021210 |
| A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention. | Journal of the American College of Cardiology 20021204 |
| Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion. | The Journal of pharmacology and experimental therapeutics 20021201 |
| Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20021201 |
| Bleeding associated with eptifibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors. | Journal of clinical pharmacology 20021201 |
| Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibition. | Thrombosis and haemostasis 20021201 |
| The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention. | The Journal of invasive cardiology 20021201 |
| Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy). | Journal of thrombosis and thrombolysis 20021201 |
| Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin. | European journal of pharmacology 20021101 |
| Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary intervention. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021101 |
| Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021101 |
| Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021101 |
| The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro. | Platelets 20021101 |
| ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). | Circulation 20021001 |
| No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors. | Pharmacogenetics 20021001 |
| Eptifibatide in percutaneous coronary intervention. A review. | Minerva cardioangiologica 20021001 |
| Combination antiplatelet therapy: implications for pharmacists. | Pharmacotherapy 20021001 |
| [Value of eptifibatide during salvage angioplasty with coronary stenting after failure of thrombolysis. Report of a series of 41 patients]. | Archives des maladies du coeur et des vaisseaux 20021001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021001 |
| Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study. | Journal of the American College of Cardiology 20020918 |
| Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. | Circulation 20020917 |
| Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. | Blood 20020915 |
| Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). | The American journal of cardiology 20020915 |
| Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). | The American journal of cardiology 20020901 |
| Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa. | Expert opinion on pharmacotherapy 20020801 |
| [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty]. | Vnitrni lekarstvi 20020801 |
| Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates. | Journal of thrombosis and thrombolysis 20020801 |
| Glycoprotein receptor inhibitors in the management of acute coronary syndromes. | Current cardiology reports 20020701 |
| Platelet glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: IIb or Not IIb, what is the question? | The Journal of invasive cardiology 20020701 |
| Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. | Internal medicine journal 20020701 |
| Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. | European heart journal 20020701 |
| Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. | American heart journal 20020701 |
| Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. | Journal of the American College of Cardiology 20020619 |
| Clinical pharmacology of bivalirudin. | Pharmacotherapy 20020601 |
| Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention. | Journal of thrombosis and thrombolysis 20020601 |
| Same-day transradial outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa receptor blockade: a feasibility study. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20020501 |
| Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for acute coronary syndromes. | The Journal of invasive cardiology 20020501 |
| Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions. | Critical care medicine 20020501 |
| Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of GpIIb/IIIa structure. | Thrombosis and haemostasis 20020501 |
| [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. | Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020501 |
| [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. | Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020501 |
| Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. | Circulation 20020423 |
| Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. | The American journal of cardiology 20020415 |
| Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies. | Thrombosis research 20020415 |
| Reversible thrombocytopenia associated with eptifibatide. | The Annals of pharmacotherapy 20020401 |
| Indications for appropriate platelet glycoprotein IIb/IIIa inhibitor therapy. | Annals of emergency medicine 20020401 |
| Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. | American heart journal 20020401 |
| Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. | American heart journal 20020401 |
| Cost efficacy of platelet glycoprotein IIb/IIIa antagonists in clinical trials and clinical practice. | Journal of interventional cardiology 20020401 |
| The efficacy and safety of perioperative antiplatelet therapy. | Journal of thrombosis and thrombolysis 20020401 |
| Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors. | Thrombosis research 20020401 |
| A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. | Circulation research 20020308 |
| Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions. | AJR. American journal of roentgenology 20020301 |
| Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries? | Journal of vascular and interventional radiology : JVIR 20020301 |
| Recent advances in antiplatelet agents. | Current medicinal chemistry 20020301 |
| Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta3 integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. | Circulation 20020212 |
| Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. | Journal of the American College of Cardiology 20020206 |
| Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. | JAMA 20020206 |
| Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? | Circulation 20020205 |
| Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. | European heart journal 20020201 |
| [Eptifibatide blocks the increase in C-reactive protein concentration after coronary angioplasty]. | Revista espanola de cardiologia 20020201 |
| The role of alpha(v)beta3 integrins in vascular healing. | Thrombosis and haemostasis 20020201 |
| The WRIST series--what have we learnt? | Herz 20020201 |
| Glycoprotein IIb/IIIa inhibitors. | Intensive & critical care nursing 20020201 |
| The pharmacodynamics of parenteral glycoprotein IIb/IIIa inhibitors. | Journal of interventional cardiology 20020201 |
| Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. | Circulation 20020122 |
| Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies. | Circulation 20020122 |
| A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides. | Journal of controlled release : official journal of the Controlled Release Society 20020117 |
| Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact. | Circulation 20020115 |
| Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy. | European heart journal 20020101 |
| Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. | American heart journal 20020101 |
| In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. | The American journal of cardiology 20020101 |
| Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion. | BMC cardiovascular disorders 20020101 |
| Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update. | Drugs 20020101 |
| Platelet glycoprotein IIb/IIIa receptor blockade with integrilin (eptifibatide) for early postinfarction angina in a patient with coronary arterial ectasia. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20020101 |
| Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention. | American journal of therapeutics 20020101 |
| In vitro anti-aggregatory effects of the GP IIb/IIIa antagonist eptifibatide on feline platelets. | Journal of veterinary internal medicine 20020101 |
| Inhibition of shear-stress-induced platelet aggregation and phosphotyrosine signaling by GPIIb-IIIa antagonists. | Annals of biomedical engineering 20020101 |
| Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy). | Cardiology 20020101 |
| Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use. | Journal of cardiac surgery 20020101 |
| [Platelet inhibitors: old and new]. | La Tunisie medicale 20020101 |
| Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy. | Circulation 20011218 |
| Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes. | Lancet (London, England) 20011208 |
| Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. | Circulation 20011204 |
| A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria. | The American journal of cardiology 20011201 |
| GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. | Cleveland Clinic journal of medicine 20011201 |
| Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). | The American journal of cardiology 20011115 |
| ESPRIT in context: pharmacology matters! | European heart journal 20011101 |
| Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial. | The American journal of cardiology 20011101 |
| Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials. | Current opinion in cardiology 20011101 |
| [Indications for intravenous GPIIb/IIIa receptor inhibitors in acute coronary syndrome without prolonged ST syndrome]. | Archives des maladies du coeur et des vaisseaux 20011101 |
| Modulation of platelet aggregation in baboons: implications for mixed chimerism in xenotransplantation. I. The roles of individual components of a transplantation conditioning regimen and of pig peripheral blood progenitor cells. | Transplantation 20011015 |
| Bleeding in a patient receiving platelet aggregation inhibitors. | Anesthesia and analgesia 20011001 |
| Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients with coronary artery disease. | Journal of cardiovascular pharmacology 20011001 |
| Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. | Italian heart journal : official journal of the Italian Federation of Cardiology 20011001 |
| Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban. | Journal of thrombosis and thrombolysis 20011001 |
| Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer. | Journal of thrombosis and thrombolysis 20011001 |
| Oral glycoprotein IIb/IIa antagonists for unstable angina--is there still a chance for the oral substances? | Thrombosis research 20010930 |
| Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation. | Circulation 20010918 |
| Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics. | Blood 20010901 |
| Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. | Journal of the American College of Cardiology 20010901 |
| Severe thrombocytopenia possibly related to readministration of eptifibatide. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20010901 |
| [Platelet glycoprotein IIb/IIIa blockade with eptifibatide in angioplasty followed by stent implantation at 6 month in the ESPRIT study]. | Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20010901 |
| Association of eptifibatide and acute profound thrombocytopenia. | The American journal of cardiology 20010815 |
| There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study. | Thrombosis research 20010815 |
| Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation. | Protein science : a publication of the Protein Society 20010801 |
| Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition. | American heart journal 20010801 |
| Comparison of eptifibatide and abciximab with decision analysis. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010801 |
| Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review. | Clinical therapeutics 20010801 |
| [Optimal thrombolysis]. | Zeitschrift fur Kardiologie 20010801 |
| Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. | Circulation 20010731 |
| Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. | Circulation 20010731 |
| AlphaIIb's cytoplasmic domain is not required for ligand-induced clustering of integrin alphaIIbbeta3. | Biochimica et biophysica acta 20010725 |
| Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT. | Circulation 20010724 |
| Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. | Circulation 20010724 |
| Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. | Blood 20010701 |
| Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes. | The American journal of cardiology 20010701 |
| Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. | The American journal of cardiology 20010701 |
| Extensive thrombus prior to elective percutaneous coronary intervention. | The Journal of invasive cardiology 20010701 |
| Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20010701 |
| Glycoprotein IIb/IIIa inhibitors: more different than alike? | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20010701 |
| Anti-GPIIb/IIIa drugs: current strategies and future directions. | Thrombosis and haemostasis 20010701 |
| Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantation. | Transplantation 20010615 |
| Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. | The American journal of cardiology 20010601 |
| Successful use of eptifibatide as an adjunct to coronary stenting in a patient with abciximab-associated acute profound thrombocytopenia. | The Journal of invasive cardiology 20010601 |
| Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy. | Circulation 20010529 |
| Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. | Circulation 20010529 |
| Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. | JAMA 20010516 |
| Stabilization of eptifibatide by cosolvents. | International journal of pharmaceutics 20010507 |
| Drug-company sponsorship and the Declaration of Helsinki. | Lancet (London, England) 20010505 |
| Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement. | Neurosurgery 20010501 |
| Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes. | Cardiology clinics 20010501 |
| Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention. | Journal of thrombosis and thrombolysis 20010501 |
| Antiplatelet agents in tissue factor-induced blood coagulation. | Blood 20010415 |
| A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20010401 |
| Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. | Journal of the American College of Cardiology 20010401 |
| In vitro dose response to different GPIIb/IIIa-antagonists: inter-laboratory comparison of various platelet function tests. | Thrombosis research 20010401 |
| Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors. | British journal of haematology 20010401 |
| [Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa inhibitors]. | Herz 20010401 |
| [GPIIb-IIIa inhibitors]. | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010401 |
| Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors. | Journal of thrombosis and thrombolysis 20010401 |
| New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction. | Archives of internal medicine 20010312 |
| Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists. | The Journal of pharmacology and experimental therapeutics 20010301 |
| Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. | The American journal of cardiology 20010301 |
| Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention. | The American journal of cardiology 20010301 |
| Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. | American heart journal 20010301 |
| Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) Trial. | American heart journal 20010301 |
| Initial experience with a newer generation coronary stent. | The Journal of invasive cardiology 20010301 |
| Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban. | Thrombosis and haemostasis 20010301 |
| Unexpected flow cytometric results with two small GPIIb/IIIa blockers: eptifibatide and tirofiban. | Thrombosis and haemostasis 20010301 |
| Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function. | Journal of the American College of Cardiology 20010301 |
| Utility of mechanical rheolysis as an adjunct to rescue angioplasty and platelet inhibition in acute myocardial infarction and cardiogenic shock: a case report. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20010201 |
| [Economic evaluation of eptifibatide]. | Revista espanola de cardiologia 20010201 |
| Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. | Journal of the American College of Cardiology 20010201 |
| [Integrin-ligands binding reaction upregulates the antioxidant activity of rabbit bronchial epithelial cells]. | Sheng li xue bao : [Acta physiologica Sinica] 20010201 |
| Rheolytic thrombectomy for in-stent thrombosis: creating a diagnostic window. | Journal of interventional cardiology 20010201 |
| [Eptifibatide (Integrilin)]. | Ugeskrift for laeger 20010122 |
| [Update on the treatment with platelet antiaggregation agents]. | Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20010101 |
| [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology]. | Vojnosanitetski pregled 20010101 |
| Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized placebo-controlled study. | Indian heart journal 20010101 |
| The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes. | Heart & lung : the journal of critical care 20010101 |
| Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromes. | Progress in cardiovascular diseases 20010101 |
| Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies. | Cardiovascular toxicology 20010101 |
| [Glycoprotein IIb/IIIa inhibitors in unstable angina]. | Annales de cardiologie et d'angeiologie 20010101 |
| [Unstable angina in the elderly]. | Annales de cardiologie et d'angeiologie 20010101 |
| Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. | Journal of medicinal chemistry 20000921 |
| Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials. | The American journal of medicine 20000815 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.